Skip to Content
Notice

Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Provisional Patent Application Concerning Monoclonal Antibodies Against Glycoprotein of Ebola Sudan Boniface Virus

Action

Notice.

Summary

Announcement is made of the availability for licensing of the invention set forth in U.S. Provisional Patent Application Serial No. 61/290,725 entitled “Monoclonal Antibodies Against Glycoprotein of Ebola Sudan Boniface Virus,” filed December 29, 2009. The United States Government, as represented by the Secretary of the Army, has rights to this invention.

 

Table of Contents Back to Top

ADDRESSES: Back to Top

Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: Back to Top

For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul Mele, Office of Research and Technology Assessment, (301) 619-6664, both at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: Back to Top

The invention relates generally to the field of antibodies. More specifically the invention relates to monoclonal antibodies against glycoproteins of the Ebola Sudan Boniface virus and methods of producing and using the same.

Brenda S. Bowen,

Army Federal Register Liaison Officer.

[FR Doc. 2010-1314 Filed 1-22-10; 8:45 am]

BILLING CODE 3710-08-P

Site Feedback